Clinical Trial: Predicting HFNC Failure in Acute Hypoxemic Respiratory Failure Using Metabolomics and Clinical Data

U.S., May 27 -- ClinicalTrials.gov registry received information related to the study (NCT07607080) titled 'Predicting HFNC Failure in Acute Hypoxemic Respiratory Failure Using Metabolomics and Clinical Data' on May 19.

Brief Summary: The goal of this observational study is to determine whether metabolomic profiles combined with clinical data can predict high-flow nasal cannula (HFNC) failure and help optimize respiratory support in adult patients with acute hypoxemic respiratory failure (AHRF). The main questions it aims to answer are:

Can metabolomic biomarkers identify patients at higher risk of HFNC failure? Does combining metabolomic and clinical data improve the prediction of respiratory support escalation and clinical outcomes?

Pa...